ATE433754T1 - Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält - Google Patents

Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält

Info

Publication number
ATE433754T1
ATE433754T1 AT01917828T AT01917828T ATE433754T1 AT E433754 T1 ATE433754 T1 AT E433754T1 AT 01917828 T AT01917828 T AT 01917828T AT 01917828 T AT01917828 T AT 01917828T AT E433754 T1 ATE433754 T1 AT E433754T1
Authority
AT
Austria
Prior art keywords
bale
liver transplantation
promoting composition
keto prostaglandin
transplantation containing
Prior art date
Application number
AT01917828T
Other languages
German (de)
English (en)
Inventor
Ryuji Ueno
Makoto Suematsu
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of ATE433754T1 publication Critical patent/ATE433754T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT01917828T 2000-04-06 2001-04-05 Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält ATE433754T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19489400P 2000-04-06 2000-04-06
PCT/JP2001/002938 WO2001076593A2 (en) 2000-04-06 2001-04-05 Bile secretion promoting composition a 15-keto prostaglandin

Publications (1)

Publication Number Publication Date
ATE433754T1 true ATE433754T1 (de) 2009-07-15

Family

ID=22719290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01917828T ATE433754T1 (de) 2000-04-06 2001-04-05 Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält

Country Status (15)

Country Link
US (2) US6469062B2 (https=)
EP (1) EP1267883B1 (https=)
JP (2) JP4183943B2 (https=)
KR (1) KR100874626B1 (https=)
CN (1) CN1241570C (https=)
AR (1) AR030277A1 (https=)
AT (1) ATE433754T1 (https=)
AU (2) AU2001244727B2 (https=)
BR (1) BR0107544A (https=)
CA (1) CA2404767C (https=)
DE (1) DE60139002D1 (https=)
MX (1) MXPA02009915A (https=)
NZ (1) NZ521784A (https=)
TW (1) TWI232750B (https=)
WO (1) WO2001076593A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267883B1 (en) * 2000-04-06 2009-06-17 Sucampo AG Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin
EP1420794B1 (en) 2001-08-31 2017-12-27 Sucampo AG Prostaglandin analogs as chloride channel openers
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) * 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
EP1575596B1 (en) * 2002-12-27 2016-06-22 Sucampo AG Derivatives of prostaglandins for treating irritable bowel syndrome and/or functional dyspepsia
RU2468800C2 (ru) * 2005-04-12 2012-12-10 Сукампо Аг Комбинированное применение производного простагландина и ингибитора протонового насоса для лечения желудочно-кишечных заболеваний
WO2007008697A2 (en) * 2005-07-08 2007-01-18 University Of Chicago Compositions and methods for refolding of denatured proteins
CA2642744C (en) * 2006-02-28 2015-02-24 Sucampo Ag Method and composition for treating chronic obstructive pulmonary disease
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
JP6957610B2 (ja) * 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ
KR102595299B1 (ko) 2020-10-12 2023-10-26 류형준 담즙 분비 촉진 효능이 있는 식품 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58203911A (ja) * 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
JPS6327433A (ja) 1986-07-21 1988-02-05 Teijin Ltd 肝疾患治療剤
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5076569A (en) * 1989-09-15 1991-12-31 Gootter Steven M Contoured grip for exercising the hand
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
TW224942B (https=) 1990-04-04 1994-06-11 Adka Ueno Kk
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
JPH069404A (ja) 1992-06-23 1994-01-18 Ono Pharmaceut Co Ltd 臓器移植用薬剤
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
EP1267883B1 (en) * 2000-04-06 2009-06-17 Sucampo AG Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin

Also Published As

Publication number Publication date
JP2008291033A (ja) 2008-12-04
JP2004519412A (ja) 2004-07-02
NZ521784A (en) 2005-04-29
KR100874626B1 (ko) 2008-12-17
US20030060506A1 (en) 2003-03-27
JP5073588B2 (ja) 2012-11-14
KR20020087123A (ko) 2002-11-21
JP4183943B2 (ja) 2008-11-19
CA2404767C (en) 2010-12-07
US6469062B2 (en) 2002-10-22
EP1267883A2 (en) 2003-01-02
CN1450899A (zh) 2003-10-22
TWI232750B (en) 2005-05-21
US20020004524A1 (en) 2002-01-10
CA2404767A1 (en) 2001-10-18
CN1241570C (zh) 2006-02-15
WO2001076593A3 (en) 2002-07-11
EP1267883B1 (en) 2009-06-17
BR0107544A (pt) 2005-01-11
AR030277A1 (es) 2003-08-20
DE60139002D1 (de) 2009-07-30
AU2001244727B2 (en) 2006-08-10
AU4472701A (en) 2001-10-23
WO2001076593A2 (en) 2001-10-18
MXPA02009915A (es) 2003-03-27

Similar Documents

Publication Publication Date Title
ID22095A (id) Asam aril-akrilat ester
ATE433754T1 (de) Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
NO20033074L (no) Antistoffer mot reseptoren for insulin-lignende vekstfaktor I
AU9013101A (en) Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
IS5714A (is) Ný 3-arýl-2-hýdroxýprópíonsýruafleiða (I)
NO20006114L (no) Nytt 3-aryl-2-hydroksypropionsyrederivat III
DE60106022D1 (de) Thiophenverbindungen zur verwendung als antikrebsmittel
DK1488790T3 (da) Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat
IT1292410B1 (it) Contenitore di pronto impiego per ottenere colla di fibrina autologa
DE60108891D1 (de) Injizierbare zusammensetzung für die vertebroplastie
PT900270E (pt) Composicao acida espessada
IS1901B (is) Efnasambönd til að hindra magasýruseytrun
ATE505445T1 (de) Tensidzusammensetzung für gipsbauplatten
ATE343564T1 (de) Immunoassay für neonicotinyl-insektizide
AU9375701A (en) Polycarboxylic acid containing three-in-one dishwashing composition
DE60115258D1 (de) Zusammensetzung für optisches material
ID15885A (id) Pembuatan alkil ester secara kontiniu dari asam met-akrilik
IS6400A (is) Kristallað form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýlfenýl}etoxý)fenýl]própanónsýra
EE200100708A (et) Asendatud fenoksüäädikhapped
ATE242183T1 (de) Glaszusammensetzung zur vermeidung der alkali- kiesel-kieselsäure reaktion
ATE337307T1 (de) Neue dihydroxyhexansäurederivate
ID23100A (id) Proses produksi untuk asam akrilat
DE69801941D1 (de) Kautschukzusammensetzungen welche o-Salicylsalicylicsäure enthalten
DE69527764D1 (de) Backtriebsäurezusammensetzung
DE69918600D1 (de) Neue Triebmittelsäurezusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties